Thoughts.
Watch this space for the latest News, Top Tips, Blogs and Master Classes from Pharmora.
Our latest thinking
News
World Autism Day
In this blog raising awareness of autism in celebration of World Autism Day (2nd April), Dr Arunesh Sil has written about his experience raising his autistic child and all that it taught him about acceptance and patience.
Rare diseases are not rare!
In this blog to support Rare Disease Day Pharmora Chief Medical Officer, Dr Stephanie Jones, has provided tips for Innovators developing new products to diagnose or treat rare diseases, and a checklist to help people affected by these conditions who are looking for these innovations.
Ovarian Cancer (3 of 3): Treatments
In the final instalment of this masterclass, we explore current available treatment options and the treatments that are in development in both the laboratory and clinical trial stages.
Top Tips
Pharmora RMP Masterclass (2): RMP Development Process -TOP TIPS
In this blog our CMO, Dr Stephanie Jones, provides detailed guidance on how to save time and effort and produce high quality risk management plans. Read on to find out more!
IDMC Tips to Help You Prepare
An Independent Data Monitoring Committee (IDMC) is a group of experts contracted to review data during a clinical trial. The members are individuals with ‘extensive clinical experience’ (Sartor et al, 2015) in that area of research, and they are independent of the Sponsor conducting the trial.
Top Tips for CSR Safety Narratives
Whether you are working with an external service provider or creating them in-house the safety narratives always cause a great deal of work right at the end of the study. This can be the busiest period when the team needs to focus on generating key messages for the completed study report (CSR) and potentially a marketing authorisation application.
Blog Posts
World Autism Day
In this blog raising awareness of autism in celebration of World Autism Day (2nd April), Dr Arunesh Sil has written about his experience raising his autistic child and all that it taught him about acceptance and patience.
Rare diseases are not rare!
In this blog to support Rare Disease Day Pharmora Chief Medical Officer, Dr Stephanie Jones, has provided tips for Innovators developing new products to diagnose or treat rare diseases, and a checklist to help people affected by these conditions who are looking for these innovations.
International Day of Women and Girls in Science (3 of 3)
This is the final instalment of our series of blogs which detail just a few women and girls’ experiences of being a woman in a scientific field. In this final blog, we hear from one of our staff about her journey from a scientifically-inclined child, to the scientist she is today.
Case Studies
Unblinded Medical Review (UMR): How does it work in Pharmora?
In a follow up to the blog outlining what unblinded medical review (UMR) means and why it might be needed, this case study from one of the UMR team explains how Pharmora can support with UMR of clinical trial data.
Unblinded Medical Review (UMR): what is it and when is it needed?
In this blog we explain what UMR means and why the Sponsors of clinical trials for investigational medicinal products might need it.
Unexpected Signal Evaluations
Pharmora helped to meet a tight deadline for submitting an application for marketing approval by reviewing multiple signals to support the safety profile.
Master Class
Ovarian Cancer (3 of 3): Treatments
In the final instalment of this masterclass, we explore current available treatment options and the treatments that are in development in both the laboratory and clinical trial stages.
Ovarian Cancer (2 of 3): Types & Statistics
In the second instalment of this masterclass, we discuss the wide variety of types and sub-types of ovarian cancer including the variations in symptoms and survival rates.
Ovarian Cancer (1 of 3): Signs & Symptoms
In the first instalment of this masterclass, we discuss the signs and symptoms that indicate ovarian cancer, along with the importance of bringing these symptoms to a healthcare professional as early as possible.
